Download Mobile App

Video Library

Partner Sites

MedImaging

New Material Boosts MRI Image Quality

AI Model Accurately Detects Placenta Accreta in Pregnancy Before Delivery

AI Model Reads and Diagnoses Brain MRI in Seconds

MRI Scan Breakthrough to Help Avoid Risky Invasive Tests for Heart Patients

Portable Ultrasound Sensor to Enable Earlier Breast Cancer Detection

Featured Links

Medical Equipment Marketplace
Visit our all new website Trademed.com where buyers and sellers can find the best medical device and equipment.

Oridis Licenses Tissue Microarray Technology

By Labmedica staff writers
Posted on 05 Dec 2006

Oridis Biomed (Graz, Austria), a biopharmaceutical company, announced that it has entered into a license agreement with the National Institutes of Health (NIH, Bethesda, MD, USA) for the worldwide commercial use of NIH's proprietary tissue microarray (TMA).

TMAs are a tool within Oridis Biomed's Tissomics platform, which permits the rapid and simultaneous study of several hundred tissue samples, using standardized high-throughput analysis by in-house pathologists.

"We are pleased to have been granted by the NIH a license for this TMA technology”, said Georg Casari, Ph.D., head of Oridis Biomed's Tissomics business. More...

"This license agreement further strengthens our Tissomics business for the life-science industry worldwide, where we offer our clients the ability to validate their research, such as biomarker and target verification programs.”

Oridis Biomed commercializes its proprietary Tissomics platform in collaboration with industrial partners, as well as its own research and development programs. The company is developing diagnostics, biomarkers (targeted treatment solutions), and therapeutics for liver diseases. Therapeutic programs include primary liver cancer (hepatocellular carcinoma, HCC) and metabolic liver diseases, such as alcoholic steatohepatitis (ASH) and non- alcoholic steatohepatitis (NASH), where incidence rates are rapidly increasing, while treatment options are limited, expensive, and often ineffective.

Related Links:
Oridis Biomed
National Institutes of Health

Visit expo >

Gold Member

STI Test

Vivalytic Sexually Transmitted Infection (STI) Array

Antipsychotic TDM Assays
Saladax Antipsychotic Assays

Mammography System (Analog)

MAM VENUS

Surgical Headlight

IsoTorch

Read the full article by registering today, it's FREE!

Free digital version edition of HospiMedica International sent by email on regular basis
Free print version of HospiMedica International magazine (available only outside USA and Canada).
Free and unlimited access to back issues of HospiMedica International in digital format
Free HospiMedica International Newsletter sent every week containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!